Royal Bank of Canada’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Sell |
31
-818
| -96% | – | ﹤0.01% | 6592 |
|
|
2025
Q1 | $2K | Sell |
849
-789
| -48% | -$1.86K | ﹤0.01% | 6158 |
|
|
2024
Q4 | $10K | Buy |
1,638
+361
| +28% | +$2.2K | ﹤0.01% | 5844 |
|
|
2024
Q3 | $9K | Buy |
1,277
+161
| +14% | +$1.14K | ﹤0.01% | 5883 |
|
|
2024
Q2 | $6K | Buy |
1,116
+838
| +301% | +$4.51K | ﹤0.01% | 6077 |
|
|
2024
Q1 | $2K | Sell |
278
-2,210
| -89% | -$15.9K | ﹤0.01% | 6191 |
|
|
2023
Q4 | $12K | Buy |
2,488
+927
| +59% | +$4.47K | ﹤0.01% | 5904 |
|
|
2023
Q3 | $15K | Buy |
1,561
+654
| +72% | +$6.28K | ﹤0.01% | 5773 |
|
|
2023
Q2 | $12K | Buy |
907
+242
| +36% | +$3.2K | ﹤0.01% | 5940 |
|
|
2023
Q1 | $8K | Buy |
+665
| New | +$8K | ﹤0.01% | 5999 |
|